CFO
TEVA icon

CVA Family Office’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

CVA Family Office’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-94
Closed -$1K – 923
2021
Q3 		$1K Hold
94
– – ﹤0.01% 355
2021
Q2 		$1K Hold
94
– – ﹤0.01% 930
2021
Q1 		$1K Hold
94
– – ﹤0.01% 762
2020
Q4 		$1K Hold
94
– – ﹤0.01% 349
2020
Q3 		$1K Hold
94
– – ﹤0.01% 355
2020
Q2 		$1K Hold
94
– – ﹤0.01% 317
2020
Q1 		$1K Buy
+94
New +$963 ﹤0.01% 302

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Abrams Capital Management
Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return
Menora Mivtachim Holdings
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
Migdal Insurance & Financial Holdings
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Clal Insurance
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
Phoenix Financial
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
Lingotto Investment Management
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

CVA Family Office's TEVA Position: Q4 2021 in Review

CVA Family Office sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q4 2021, closing a stake of 94 shares — an estimated $1K sold.

CVA Family Office first reported a position in TEVA in Q1 2020 and held it in 7 quarters. The position peaked at $1K in Q3 2021. 450 funds tracked by Wall St. Rank hold TEVA as of Q4 2021.

  • CVA Family Office reported no remaining Teva Pharmaceutical Industries Limited position as of Q4 2021 after selling out during the quarter.
  • CVA Family Office sold 94 Teva Pharmaceutical Industries Limited shares in Q4 2021, an estimated $1K.
  • CVA Family Office first reported a position in Teva Pharmaceutical Industries Limited in Q1 2020 and held it in 7 quarters.
  • CVA Family Office's Teva Pharmaceutical Industries Limited position peaked at $1K in Q3 2021.
  • 450 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q4 2021.

Based on CVA Family Office's 13F filing for Q4 2021, filed 25 Jan 2022.